SecuritySLDA / Sutherland Asset Management Corp (86933G105)
CEO, President and DirectorSzymanski Michael
IndustryReal Estate Investment Trusts
Institutional Owners66
Institutional Shares10,137,914 - 31.68%
Common Stock Shares Outstanding31,996,440 shares (as of 2018-03-31)
Institutional Value$ 306,112,000 USD
Related SLD / Sutherland Assest Management Corp.
ZFC / ZAIS Financial Corp.

Institutional Stock Ownership and Shareholders()

Sutherland Asset Management Corp (NYSE:SLDA) has 66 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 10,137,914 shares. Largest shareholders include Farallon Capital Management Llc, American Financial Group Inc, BlackRock Inc., Vanguard Group Inc, Raymond James & Associates, Tcw Group Inc, State Street Corp, West Family Investments, Inc., Northern Trust Corp, and BlackRock Institutional Trust Company, N.A..
Sutherland Asset Management Corp (NYSE:SLDA) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 6,167 6,167 0.00 93 93,430 100,362.37
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 26,723 0 -100.00 405 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 810,781 807,018 -0.46 12,283 12,226 -0.46
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 28,000 39,800 42.14 425 603 41.88
2018-05-16 13F-HR ASSETMARK, INC 9,715 147
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 13,824 26,133 89.04 210 396 88.57
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 10,313 0 -100.00 155 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 112,591 79,778 -29.14 1,706 1,209 -29.13
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 11,845 11,241 -5.10 179 170 -5.03
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 41,625 40,841 -1.88 631 619 -1.90
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 5,340 3,951 -26.01 80,901 59,858 -26.01
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 725,719 735,169 1.30 10,995 11,138 1.30
2018-05-11 13F-HR CITIGROUP INC 11,121 6,937 -37.62 168 104 -38.10
2018-05-15 13F-HR Paloma Partners Management Co 93,779 0 -100.00 1,421 0 -100.00
2018-05-16 13F-HR Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp 13,200 0 -100.00 200 0 -100.00
2018-04-19 13F-HR Orinda Asset Management LLC 20,000 303
2018-04-20 13F-HR Varma Mutual Pension Insurance Co 77,283 77,283 0.00 1,170 1,170 0.00
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 1,102 2,282 107.08 16 35 118.75
2018-05-09 13F-HR NORTHERN TRUST CORP 194,233 198,596 2.25 2,942 3,009 2.28
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 27,853 26,685 -4.19 422 404 -4.27
2018-05-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 24,174 26,808 10.90 366 406 10.93
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 27,953 27,105 -3.03 423 411 -2.84
2018-05-14 13F-HR BB&T SECURITIES, LLC 43,077 40,896 -5.06 652 619 -5.06
2017-02-10 13F-HR BlackRock Investment Management, LLC 1,961 26
2018-05-15 13F-HR Metlife Investment Advisors, Llc 8,791 8,791 0.00 133 133 0.00
2018-05-10 13F-HR JP Morgan Chase & Co 59,499 59,247 -0.42 901 898 -0.33
2018-05-12 13F-HR Hillsdale Investment Management Inc. 300 320 6.67 5 5 0.00
2018-05-15 13F-HR Invesco Ltd. 0 44,225 0 670
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 187,326 2,520
2018-05-15 13F-HR MENTA CAPITAL LLC 12,588 0 -100.00 191 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 3,089 3,666 18.68 47 56 19.15
2018-04-13 13F-HR North Star Investment Management Corp. 309 309 0.00 5 5 0.00
2018-05-15 13F-HR Sterling Capital Management LLC 50,703 0 -100.00 768 0 -100.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 5,274 11,829 124.29 80 180 125.00
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 1,052 0 -100.00 16 0 -100.00
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 18,100 18,100 0.00 274 274 0.00
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 82,631 147,691 78.74 1,252 2,237 78.67
2018-05-11 13F-HR AMERICAN FINANCIAL GROUP INC 1,480,212 1,480,212 0.00 22,425 22,425 0.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 32,144 32,144 0.00 487 487 0.00
2018-05-15 13F-HR CREDIT SUISSE AG/ 15,784 17,055 8.05 238 258 8.40
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 1,486 1,486 0.00 23 23 0.00
2018-05-14 13F-HR MORGAN STANLEY 99,612 65,623 -34.12 1,509 995 -34.06
2018-04-20 13F-HR STRS OHIO 4,900 4,900 0.00 74 74 0.00
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 33,450 32,179 -3.80 507 488 -3.75
2018-05-14 13F-HR Archford Capital Strategies, LLC 0 217 0 3
2018-05-23 13F-HR/A Allianz Asset Management AG 68,563 1,038
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 117,793 113,255 -3.85 1,784 1,715 -3.87
2018-05-14 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 84,597 56,311 -33.44 1,282 853 -33.46
2018-05-04 13F-HR VIRGINIA RETIREMENT SYSTEMS ET AL 23,900 362
2018-05-02 13F-HR RHUMBLINE ADVISERS 15,114 14,414 -4.63 229 218 -4.80
2018-05-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 39,528 0 -100.00 599 0 -100.00
2018-05-08 13F-HR State of New Jersey Common Pension Fund D 124,000 139,000 12.10 1,879 2,106 12.08
2018-05-15 13F-HR QS Investors, LLC 28 28 0.00 1 1 0.00
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 1,800 1,800 0.00 27 27 0.00
2018-05-09 13F-HR BlackRock Inc. 1,425,650 1,386,551 -2.74 21,598 21,005 -2.75
2018-05-10 13F-HR TCW GROUP INC 369,179 466,525 26.37 5,593 7,068 26.37
2018-02-12 13F-HR Hutchin Hill Capital, LP 17,300 17,300 0.00 272 262 -3.68
2017-02-10 13F-HR BlackRock Fund Advisors 167,774 2,257
2018-05-15 13F-HR STATE STREET CORP 288,934 448,829 55.34 4,376 6,800 55.39
2018-05-15 13F-HR Bank of New York Mellon Corp 66,677 68,214 2.31 1,011 1,034 2.27
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 14,615 14,979 2.49 221 227 2.71
2018-05-15 13F-HR FARALLON CAPITAL MANAGEMENT LLC 2,200,007 2,208,239 0.37 33,330 33,455 0.38
2018-05-14 13F-HR Renaissance Technologies LLC 193,300 67,400 -65.13 2,928 1,021 -65.13
2018-05-10 13F-HR West Family Investments, Inc. 410,322 410,322 0.00 6,216 6,216 0.00
2018-04-23 13F-HR FIRST TRUST ADVISORS LP 14,034 15,059 7.30 213 228 7.04
2018-05-17 13F-HR Legal & General Group Plc 4,494 3,322 -26.08 68 50 -26.47
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 10,791 9,025 -16.37 163 136 -16.56
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 25,975 19,775 -23.87 394 300 -23.86
2018-05-15 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 6,573 100
2017-11-09 13F-HR TFS CAPITAL LLC 15,757 0 -100.00 234 0 -100.00
2018-05-04 13F-HR Swiss National Bank 29,400 29,400 0.00 445 445 0.00
2018-04-06 13F-HR Eqis Capital Management, Inc. 25,264 29,831 18.08 383 452 18.02
2018-05-15 13F-HR UBS Group AG 15,937 7,252 -54.50 241 110 -54.36
2018-05-18 13F-HR LEVIN CAPITAL STRATEGIES, L.P. 23,209 0 -100.00 352 0 -100.00
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 10,200 20,883 104.74 155 316 103.87
2018-05-15 13F-HR DEUTSCHE BANK AG\ 102,518 19,704 -80.78 1,552 296 -80.93

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Cushion Your Portfolio with These 5 High Yielding Stocks

17h zacks
After an exponential rise throughout 2017, the U.S. stock markets have been witnessing turmoil since February 2018. Factors like inflationary concerns, impending interest rate hike, global trade war fear, geopolitical conflicts in the Middle East, political turmoil in Europe, oil price fluctuations and many more, have heightened market fluctuations. Investment in high-dividend paying stocks, over a reasonable time period, is likely to bring good returns, especially when the market is plagued with severe volatility. (13-0)

5 Top Stocks to Beat the Fastest Rise in Inflation in 6 Years

2018-06-13 zacks
Cost of living for Americans rose last month at the fastest pace in six years, indicating a strong U.S. economy and tighter labor market. An uptick in gas prices and higher rent pushed up U.S. inflation, taking a bite out of household income and putting consumers under pressure. (23-0)

17 'Safer' Dividend Real Estate WallStars From May

2018-05-29 seekingalpha
Top net gain "safer" dividend Real Estate WallStars averaged 22.6% net as of May 25, 2018. Six were also top yielders. (56-0)

Top 51 Real Estate WallStars Flaunt Yields To 12.2% And Target Gains To 111.3% By May 2019

2018-05-29 seekingalpha
IRSA Propiedades led by net gains, while Two Harbors led by yield. Top ten gainers, GLPI, AJX, BPY, RESI, HASI, APTS, LMRK, CLNS, IRS, & IRCP gains ranged 17.8%-111.3% 5/25/18. (64-1)

Sutherland Asset Management's (SLD) CEO Tom Capasse on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Sutherland Asset Management Corporation (NYSE:SLD) Q1 2018 Results Conference Call May 9, 2018 8:30 AM ET (38-0)

CUSIP: 86933G105